Najib Dally

1.2k total citations
36 papers, 388 citations indexed

About

Najib Dally is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Najib Dally has authored 36 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Hematology and 10 papers in Oncology. Recurrent topics in Najib Dally's work include Chronic Lymphocytic Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Najib Dally is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Najib Dally collaborates with scholars based in Israel, United Kingdom and Spain. Najib Dally's co-authors include Andrei Braester, Tamar Tadmor, Lev Shvidel, Osnat Bairey, Aaron Polliack, Gilad Itchaki, Galia Rahav, Gerwyn Hughes, Ohad Benjamini and Riva Fineman and has published in prestigious journals such as Blood, PLoS ONE and Annals of Surgery.

In The Last Decade

Najib Dally

35 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Najib Dally Israel 10 165 127 107 76 52 36 388
Umar Zahid United States 10 187 1.1× 71 0.6× 24 0.2× 61 0.8× 60 1.2× 35 437
P. Cervi United Kingdom 8 106 0.6× 50 0.4× 89 0.8× 66 0.9× 41 0.8× 15 339
Andreas Beilken Germany 12 112 0.7× 118 0.9× 50 0.5× 21 0.3× 141 2.7× 21 454
Giulio Trapè Italy 10 107 0.6× 68 0.5× 46 0.4× 30 0.4× 73 1.4× 15 294
Valkal Bhatt United States 12 135 0.8× 70 0.6× 42 0.4× 45 0.6× 145 2.8× 46 383
L. S. Zubarovskaya Russia 9 62 0.4× 78 0.6× 34 0.3× 49 0.6× 64 1.2× 140 297
Pervin Topçuoğlu Türkiye 10 104 0.6× 30 0.2× 66 0.6× 45 0.6× 34 0.7× 69 329
Hamayun Imran United States 9 62 0.4× 103 0.8× 106 1.0× 60 0.8× 60 1.2× 25 389
Philip Campbell Australia 12 101 0.6× 34 0.3× 101 0.9× 41 0.5× 41 0.8× 44 356
John Doyle Canada 14 147 0.9× 80 0.6× 81 0.8× 66 0.9× 100 1.9× 27 698

Countries citing papers authored by Najib Dally

Since Specialization
Citations

This map shows the geographic impact of Najib Dally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Najib Dally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Najib Dally more than expected).

Fields of papers citing papers by Najib Dally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Najib Dally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Najib Dally. The network helps show where Najib Dally may publish in the future.

Co-authorship network of co-authors of Najib Dally

This figure shows the co-authorship network connecting the top 25 collaborators of Najib Dally. A scholar is included among the top collaborators of Najib Dally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Najib Dally. Najib Dally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Honig, Asaf, Hen Hallevi, Eitan Auriel, et al.. (2024). Efficacy and safety of Apixaban in the treatment of cerebral venous sinus thrombosis: a multi-center study. Frontiers in Neurology. 15. 1404099–1404099. 1 indexed citations
2.
Braester, Andrei, et al.. (2023). The role of blood inflammatory markers in the preoperative diagnosis of acute appendicitis. International Journal of Laboratory Hematology. 46(1). 58–62. 4 indexed citations
3.
Fernández‐Capitán, Carmen, Yale Tung‐Chen, Aitor Ballaz, et al.. (2023). Clinical Significance and Outcome in Patients with Asymptomatic Versus Symptomatic Subsegmental Pulmonary Embolism. Journal of Clinical Medicine. 12(4). 1640–1640. 4 indexed citations
4.
5.
Benjamini, Ohad, Lior Rokach, Gilad Itchaki, et al.. (2021). Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Haematologica. 107(3). 625–634. 73 indexed citations
6.
Avivi, Irit, Moshe E. Gatt, Efrat Luttwak, et al.. (2020). The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data. Leukemia Research. 97. 106429–106429. 1 indexed citations
7.
Michelis, Regina, Tamar Tadmor, Mona Shehadeh, et al.. (2019). A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity. PLoS ONE. 14(1). e0209024–e0209024. 7 indexed citations
8.
Zysberg, Leehu, et al.. (2019). A New Take on a Resource-Based Model of Quality of Life in Hemato-Oncological Patients: Demographic, Personal, and Social Factors. Journal of Clinical Psychology in Medical Settings. 26(4). 430–439. 6 indexed citations
9.
Bentur, Ohad S., Eldad J. Dann, Esther Paran, et al.. (2019). Interim PET-CT–guided therapy in elderly patients with Hodgkin lymphoma—a retrospective national multi-center study. Annals of Hematology. 98(7). 1665–1674. 5 indexed citations
10.
Tadmor, Tamar, Ilana Levy, Yair Herishanu, et al.. (2019). Primary peg-filgrastim prophylaxis versus filgrastim given “on demand” for neutropenia during therapy with cladribine for hairy cell leukemia. Leukemia Research. 82. 24–28. 2 indexed citations
11.
Benyamini, Noam, Moshe E. Gatt, Yaël C. Cohen, et al.. (2018). Real-Life Data on the Outcome of Daratumomab-Refractory Myeloma Patients: Multi-Center Experience. Blood. 132(Supplement 1). 3259–3259. 2 indexed citations
12.
Herishanu, Yair, Neta Goldschmidt, Osnat Bairey, et al.. (2018). Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel. Anticancer Research. 38(11). 6423–6429. 8 indexed citations
13.
14.
Farah, Raymond, et al.. (2017). The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD. Panminerva Medica. 59(3). 203–209. 39 indexed citations
15.
Dally, Najib, et al.. (2017). Ectopic Expression of Snail and Twist in Ph+ Leukemia Cells Upregulates CD44 Expression and Alters Their Differentiation Potential. Journal of Cancer. 8(19). 3952–3968. 9 indexed citations
16.
Ellis, Martin, Noa Lavi, Elena Mishchenko, et al.. (2015). Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice. Leukemia Research. 39(11). 1154–1158. 7 indexed citations
17.
Waksman, Igor, et al.. (2015). Analysis of the First 100 Patients From the Syrian Civil War Treated in an Israeli District Hospital. Annals of Surgery. 263(1). 205–209. 17 indexed citations
18.
Dally, Najib, et al.. (2015). Insights into direct anticoagulants. Blood Coagulation & Fibrinolysis. 26(5). 492–498. 1 indexed citations
19.
Sharabi‐Nov, Adi, et al.. (2012). Differentiating ischemic from non-ischemic chest pain using white blood cell-surface inflammatory and coagulation markers. Journal of Thrombosis and Thrombolysis. 34(2). 235–243. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Umar Zahid Breakdown of academic impact, for papers by P. Cervi Breakdown of academic impact, for papers by Andreas Beilken Breakdown of academic impact, for papers by Giulio Trapè Breakdown of academic impact, for papers by Valkal Bhatt Breakdown of academic impact, for papers by L. S. Zubarovskaya Breakdown of academic impact, for papers by Pervin Topçuoğlu Breakdown of academic impact, for papers by Hamayun Imran Breakdown of academic impact, for papers by Philip Campbell Breakdown of academic impact, for papers by John Doyle
Rankless by CCL
2026